Group 1 - The company announced that its subsidiary, Shandong Luhua Senxuan New Materials Co., Ltd., has led the formulation of the industry standard for 1,3-Dioxolane, which has been approved by the National Standardization Administration [2] - The standard (number: HG/T6387-2025) will officially come into effect on March 1, 2026, as announced by the Ministry of Industry and Information Technology of the People's Republic of China [2]

Group 1 - The company Jinghua Pharmaceutical (002349.SZ) announced that its subsidiary Shandong Luhua Senxuan New Materials Co., Ltd. led the formulation of the industry standard for 1,3-Dioxolane, which has been approved by the National Standardization Administration and will be implemented on March 1, 2026 [1]

Group 1 - The company, Jinghua Pharmaceutical, announced that its subsidiary, Shandong Luhuasenxuan New Materials Co., Ltd., led the formulation of the industry standard for "1,3-Dioxolane" [1] - The industry standard has been approved by the National Standardization Administration and will be officially implemented on March 1, 2026 [1]

Group 1 - The core point of the article is that the industry standard for "1,3-Dioxolane" has been approved by the National Standardization Administration and will be implemented starting March 1, 2026 [1] Group 2 - The standard was led by Shandong Luhuasenxuan New Materials Co., Ltd., a subsidiary of Jinghua Pharmaceutical [1] - The announcement was made by the Ministry of Industry and Information Technology [1]

精华制药公告，近日，由公司孙公司山东鲁化森萱新材料有限公司牵头制定的《13-二氧戊环》行业标 准（标准号：HG/T6387-2025）通过国家标委会评审，并经中华人民共和国工业和信息化部发布公告， 该标准于2026年3月1日起正式实施。 ...

证券代码：002349 证券简称：精华制药 公告编号：2025-036 精华制药集团股份有限公司 关于孙公司牵头制定产品行业标准的公告 公司将以此行业标准发布、实施为新的起点，不断提高产品质量和管控措施， 进一步树立公司品牌形象，助推企业高质量发展。 特此公告。 精华制药集团股份有限公司董事会 2025 年 9 月 17 日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误 导性陈述或者重大遗漏。 近日，由公司孙公司山东鲁化森萱新材料有限公司（以下简称"鲁化森萱"） 牵头制定的《1,3-二氧戊环》行业标准（标准号：HG/T6387-2025）通过国家标 委会评审，并经中华人民共和国工业和信息化部发布公告，该标准于 2026 年 3 月 1 日起正式实施。 ...

Core Viewpoint - The company, Jinghua Pharmaceutical, confirmed that its subsidiary, Luhua Senxuan, is a major domestic supplier of dioxane, which is currently not used in solid-state batteries [1] Group 1 - Jinghua Pharmaceutical responded to investor inquiries on September 12 regarding its subsidiary's production of dioxane [1] - Luhua Senxuan is identified as one of the main suppliers of dioxane in China [1]

Group 1 - The core point of the article is that Jinghua Pharmaceutical (002349.SZ) has clarified that its subsidiary, Luhua Senxuan, is not currently using dioxane in solid-state batteries, while the company is one of the major suppliers of dioxane in China [1]

Core Viewpoint - The company, Jinghua Pharmaceutical, confirmed that its subsidiary, Luhua Senxuan, does not currently use dioxane for solid-state batteries, although it is one of the major suppliers of dioxane in China [2] Group 1 - Investors inquired about the potential use of dioxane produced by Luhua Senxuan in solid-state batteries and its market share in the industry [2] - Jinghua Pharmaceutical stated that dioxane is not currently utilized in solid-state batteries [2] - The company is recognized as one of the main suppliers of dioxane in the domestic market [2]

Group 1 - The core inquiry from investors is about the annual production capacity of 2,5-dimethylfuran produced by the subsidiary Luhua Senxuan and whether there are plans for production expansion [2] - Luhua Senxuan primarily uses 2,5-dimethylfuran for the synthesis of urea-formaldehyde resin, with a portion utilized in the electrolyte for lithium iron phosphate batteries, but it is currently not used in solid-state batteries [2]